Eli Lilly and Company (LLY.MX)

14,400.00

0.00

(0.00%)

At close: May 9 at 1:44:50 PM CST

US-China trade truce, April CPI, drug prices: 3 Things

US stock futures (ES=F, NQ=F, YM=F) are surging Monday morning after US and China officials agreed to significant cuts to each country's respective tariff rates in a 90-day cool-off period. April's Consumer Price Index (CPI) is due out tomorrow, reporting month-over-month trends in US inflation rates. President Trump vows to cut prescription drug prices by as much as 80%. In turn, pharmaceutical stocks are seeing across the board pullbacks in pre-market trading. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 17 minutes ago

ES=F

PFE

JNJ
These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, RH, Newmont, and More

Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to temporarily slash most tariffs on each other’s goods, while Eli Lilly and Pfizer fall after President Donald Trump plans to sign an executive order that would reduce the cost of drugs in the U.S.

Barrons.com 23 minutes ago

LLY

TSLA

PFE
Novo Nordisk Stock Is Slumping Today. Here’s Why.

Shares of the Ozempic-maker fell while the rest of the market rose,as it's facing a hit to revenue from different directions.

Barrons.com 1 hour ago

NVO

LLY
Novo Nordisk Tumbles as Lilly's Zepbound Shows Greater Weight Loss in Trial

Eli Lilly's Zepbound Beats Wegovy, Sends Novo Nordisk Stock Lower

GuruFocus.com 1 hour ago

NVO

LLY
Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices

Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of medicines for Americans by 59%. Shares of major U.S. drugmakers Eli Lilly Pfizer Merck AbbVie and Amgen fell between 2.4% and 4.3% in premarket trading Monday. The U.S. is the largest market for many global pharmaceutical companies, partly because of higher prices.

Barrons.com 1 hour ago

PFE

LLY
Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower

(Bloomberg) -- President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, spurring a drop in pharmaceutical shares worldwide.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?NYC Warns of 17% D

Bloomberg 1 hour ago

BERZ

BMO

AZN
Trending tickers: Tesla, Alibaba, Eli Lilly, Novo Nordisk and Glencore

The latest investor updates on stocks that are trending on Monday.

Yahoo Finance UK 3 hours ago

RGTI

RGTIW

BABA
Lilly-Purdue partnership to invest $250m in pharma innovation

The partnership is anticipated to yield economic benefits for Indiana, enhancing innovation locally.

Pharmaceutical Technology 4 hours ago

LLY
Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices

(Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries, prompting concern that profits will take a hit.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to R

Bloomberg 4 hours ago

C

TAK

TKPHF
3 Healthcare Stocks to Keep an Eye On

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 13%. This drop was worse than the S&P 500’s 5.5% loss.

StockStory 8 hours ago

SYK

LLY
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

The data is the first head-to-head trial comparing the wildly popular medicines, and gives Lilly more firepower as it seeks to gain wider insurance coverage in an obesity drug market estimated to reach more than $150 billion annually by the next decade. Zepbound helped nearly 25% more participants lose more than 15% of their weight compared to Wegovy, Lilly said on Sunday.

Reuters 15 hours ago

LLY

NVO
Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

Eli Lilly and Company (NYSE: LLY) today announced detailed results from SURMOUNT-5, a Phase 3b open-label clinical trial, evaluating the safety and efficacy of Zepbound (tirzepatide), a dual GIP and GLP-1 receptor agonist, compared to Wegovy (semaglutide), a mono GLP-1 receptor agonist, in adults living with obesity, or overweight with at least one weight-related medical problem and without diabetes. At 72 weeks, Zepbound met the primary endpoint and all five key secondary endpoints, demonstrati

PR Newswire 15 hours ago

LLY
President Trump Just Announced Terrible News for Eli Lilly Investors

President Donald Trump vowed to impose tariffs on pharmaceuticals within two weeks. Eli Lilly, a leader in the industry, could be harmed by the move, but it is already preparing for it. President Donald Trump's second term in office has been challenging for investors, at least so far.

Motley Fool yesterday

LLY
Prediction: These 2 Stocks Will Join the Trillion-Dollar Club by 2030

Eli Lilly and Visa are closing in on a $1 trillion market cap. There is a small, exclusive group of companies with market caps above $1 trillion. Investors want to find companies that can perform well over the long run, even with market caps above $1 trillion.

Motley Fool yesterday

LLY

V
Is Eli Lilly and Company (LLY) the Best Income Stock to Invest in Now?

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional […]

Insider Monkey 2 days ago

LLY
PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co

Insights from the First Quarter of 2025

GuruFocus.com 2 days ago

LLY
Nektar Q1 Loss Wider Than Expected, Revenues Fall Y/Y, Stock Down

NKTR incurs a wider-than-expected loss in the first quarter of 2025. Revenues plunge year over year. Shares fall in after-hours trading.

Zacks 3 days ago

NKTR

LLY
Wall Street Brings the Bitcoin-Versus-Gold Clash to ETF Masses

(Bloomberg) -- The culture clash between Bitcoin enthusiasts and gold bugs is about to be played out in the world of exchange-traded funds.Most Read from BloombergIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?As Trump Reshapes Housing Policy, Renters Face Rollback of RightsVail to Borrow Muni Debt to Ease Ski Resort Town Housing CrunchNYC Warns of 17% Drop in Foreign Tourists Due to Trump PoliciesWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Tidal Fina

Bloomberg 3 days ago

F

COIN

TSLA
Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation

Eli Lilly and Company (NYSE: LLY) and Purdue University announced today a significant expansion of their long-standing alliance, with Lilly's planned investment of up to $250 million in the collaboration over the next eight years. This partnership, which has the potential to be the largest ever industry-academic agreement of its kind in the United States, will seek to accelerate innovation at every stage of the pharmaceutical pipeline.

PR Newswire 3 days ago

LLY
Eli Lilly extends Purdue alliance; EMA investigates Valneva shot

The big pharma will spend up to $250 million over the next eight years of the collaboration. Elsewhere, CRISPR Therapeutics unveiled new data and Vivo Capital raised funds.

BioPharma Dive 3 days ago

LLY

CRL

VLA.PA

Performance Overview

Return	LLY.MX	S&P 500 (^GSPC)
YTD	-10.03%	-3.77%
1-Year	+10.52%	+8.55%
3-Year	+144.42%	+41.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

TARIFFS LATEST

Eli Lilly and Company (LLY.MX)

US-China trade truce, April CPI, drug prices: 3 Things

These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, RH, Newmont, and More

Novo Nordisk Stock Is Slumping Today. Here’s Why.

Novo Nordisk Tumbles as Lilly's Zepbound Shows Greater Weight Loss in Trial

Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices

Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower

Trending tickers: Tesla, Alibaba, Eli Lilly, Novo Nordisk and Glencore

Lilly-Purdue partnership to invest $250m in pharma innovation

Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices

3 Healthcare Stocks to Keep an Eye On

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

President Trump Just Announced Terrible News for Eli Lilly Investors

Prediction: These 2 Stocks Will Join the Trillion-Dollar Club by 2030

Is Eli Lilly and Company (LLY) the Best Income Stock to Invest in Now?

PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co

Nektar Q1 Loss Wider Than Expected, Revenues Fall Y/Y, Stock Down

Wall Street Brings the Bitcoin-Versus-Gold Clash to ETF Masses

Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation

Eli Lilly extends Purdue alliance; EMA investigates Valneva shot

Performance Overview